- Home
- APVO vs VERO Comparison
APVO vs VERO Comparison
Compare APVO & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- VERO
- Stock Information
- Founded
- APVO 2016
- VERO N/A
- Country
- APVO United States
- VERO Canada
- Employees
- APVO N/A
- VERO N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- APVO Health Care
- VERO Health Care
- Exchange
- APVO Nasdaq
- VERO Nasdaq
- Market Cap
- APVO 4.1M
- VERO 4.5M
- IPO Year
- APVO N/A
- VERO N/A
- Fundamental
- Price
- APVO $1.61
- VERO $2.28
- Analyst Decision
- APVO Strong Buy
- VERO
- Analyst Count
- APVO 1
- VERO 0
- Target Price
- APVO $5,920.00
- VERO N/A
- AVG Volume (30 Days)
- APVO 162.7K
- VERO 42.9K
- Earning Date
- APVO 11-06-2025
- VERO 08-14-2025
- Dividend Yield
- APVO N/A
- VERO N/A
- EPS Growth
- APVO N/A
- VERO N/A
- EPS
- APVO N/A
- VERO N/A
- Revenue
- APVO N/A
- VERO $60,107,000.00
- Revenue This Year
- APVO N/A
- VERO N/A
- Revenue Next Year
- APVO N/A
- VERO $7.51
- P/E Ratio
- APVO N/A
- VERO N/A
- Revenue Growth
- APVO N/A
- VERO N/A
- 52 Week Low
- APVO $1.54
- VERO $2.10
- 52 Week High
- APVO $381.10
- VERO $14.50
- Technical
- Relative Strength Index (RSI)
- APVO 28.32
- VERO 43.68
- Support Level
- APVO $1.56
- VERO $2.11
- Resistance Level
- APVO $1.73
- VERO $2.78
- Average True Range (ATR)
- APVO 0.14
- VERO 0.16
- MACD
- APVO 0.02
- VERO -0.01
- Stochastic Oscillator
- APVO 11.29
- VERO 25.82
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.